BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 10725715)

  • 1. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation.
    Hwu P; Du MX; Lapointe R; Do M; Taylor MW; Young HA
    J Immunol; 2000 Apr; 164(7):3596-9. PubMed ID: 10725715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells.
    Boasso A; Herbeuval JP; Hardy AW; Winkler C; Shearer GM
    Blood; 2005 Feb; 105(4):1574-81. PubMed ID: 15466932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells.
    Munn DH; Sharma MD; Mellor AL
    J Immunol; 2004 Apr; 172(7):4100-10. PubMed ID: 15034022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of allogeneic T-cell responses by dendritic cells expressing transduced indoleamine 2,3-dioxygenase.
    Funeshima N; Fujino M; Kitazawa Y; Hara Y; Hara Y; Hayakawa K; Okuyama T; Kimura H; Li XK
    J Gene Med; 2005 May; 7(5):565-75. PubMed ID: 15543532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase.
    Mellor AL; Chandler P; Baban B; Hansen AM; Marshall B; Pihkala J; Waldmann H; Cobbold S; Adams E; Munn DH
    Int Immunol; 2004 Oct; 16(10):1391-401. PubMed ID: 15351783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites.
    Terness P; Bauer TM; Röse L; Dufter C; Watzlik A; Simon H; Opelz G
    J Exp Med; 2002 Aug; 196(4):447-57. PubMed ID: 12186837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of human auto- and alloreactive T cells by indoleamine 2,3-dioxygenase (IDO)-producing dendritic cells: too much ado about IDO?
    Terness P; Chuang JJ; Bauer T; Jiga L; Opelz G
    Blood; 2005 Mar; 105(6):2480-6. PubMed ID: 15572592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma-triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells.
    Jürgens B; Hainz U; Fuchs D; Felzmann T; Heitger A
    Blood; 2009 Oct; 114(15):3235-43. PubMed ID: 19625705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased indoleamine 2,3-dioxygenase expression in dendritic cells and role of indoleamine 2,3-dioxygenase-expressing dendritic cells in immune thrombocytopenia.
    Xu SQ; Wang CY; Zhu XJ; Dong XY; Shi Y; Peng J; Qin P; Sun JZ; Guo C; Ni H; Hou M
    Ann Hematol; 2012 Oct; 91(10):1623-31. PubMed ID: 22526360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indoleamine 2,3-dioxygenase and regulatory function: tryptophan starvation and beyond.
    Orabona C; Grohmann U
    Methods Mol Biol; 2011; 677():269-80. PubMed ID: 20941617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDllc+ cells modulate pulmonary immune responses by production of indoleamine 2,3-dioxygenase.
    Swanson KA; Zheng Y; Heidler KM; Mizobuchi T; Wilkes DS
    Am J Respir Cell Mol Biol; 2004 Mar; 30(3):311-8. PubMed ID: 12959949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance, DCs and tryptophan: much ado about IDO.
    Grohmann U; Fallarino F; Puccetti P
    Trends Immunol; 2003 May; 24(5):242-8. PubMed ID: 12738417
    [No Abstract]   [Full Text] [Related]  

  • 13. Human type 1 and type 2 conventional dendritic cells express indoleamine 2,3-dioxygenase 1 with functional effects on T cell priming.
    Sittig SP; van Beek JJP; Flórez-Grau G; Weiden J; Buschow SI; van der Net MC; van Slooten R; Verbeek MM; Geurtz PBH; Textor J; Figdor CG; de Vries IJM; Schreibelt G
    Eur J Immunol; 2021 Jun; 51(6):1494-1504. PubMed ID: 33675038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation.
    Meisel R; Zibert A; Laryea M; Göbel U; Däubener W; Dilloo D
    Blood; 2004 Jun; 103(12):4619-21. PubMed ID: 15001472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune cell proliferation is suppressed by the interferon-gamma-induced indoleamine 2,3-dioxygenase expression of fibroblasts populated in collagen gel (FPCG).
    Sarkhosh K; Tredget EE; Karami A; Uludag H; Iwashina T; Kilani RT; Ghahary A
    J Cell Biochem; 2003 Sep; 90(1):206-17. PubMed ID: 12938169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of indoleamine 2,3-dioxygenase in the anti-tumour activity of human interferon-gamma in vivo.
    Burke F; Knowles RG; East N; Balkwill FR
    Int J Cancer; 1995 Jan; 60(1):115-22. PubMed ID: 7814143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temperature-sensitive polymer-conjugated IFN-gamma induces the expression of IDO mRNA and activity by fibroblasts populated in collagen gel (FPCG).
    Sarkhosh K; Tredget EE; Uludag H; Kilani RT; Karami A; Li Y; Iwashina T; Ghahary A
    J Cell Physiol; 2004 Oct; 201(1):146-54. PubMed ID: 15281097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human primary CD4 + T cells activated in the presence of IFN-alpha 2b express functional indoleamine 2,3-dioxygenase.
    Curreli S; Romerio F; Mirandola P; Barion P; Bemis K; Zella D
    J Interferon Cytokine Res; 2001 Jun; 21(6):431-7. PubMed ID: 11440641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synovial autoreactive T cells in rheumatoid arthritis resist IDO-mediated inhibition.
    Zhu L; Ji F; Wang Y; Zhang Y; Liu Q; Zhang JZ; Matsushima K; Cao Q; Zhang Y
    J Immunol; 2006 Dec; 177(11):8226-33. PubMed ID: 17114500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-specific T cell functions are suppressed over the estrogen-dendritic cell-indoleamine 2,3-dioxygenase axis.
    Xiao BG; Liu X; Link H
    Steroids; 2004 Sep; 69(10):653-9. PubMed ID: 15465110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.